David Mayer has been named a partner at Abingworth (London). He will be based at the life sciences investment group's offices in Waltham, Massachusetts. Mayer most recently was a managing partner at Thoma Cressey Equity Partners.

Anthony Bihl III was named president/CEO of American Medical Systems Holdings (Minneapolis). Bihl succeeds Ross Longhini, who has served as interim CEO since January. Longhini will remain in his role as executive VP and COO. Bihl joins AMS from Siemens Medical Systems, where he was CEO of the diagnostics division. American Medical Systems makes products to cure erectile dysfunction, benign prostatic hyperplasia, incontinence, menorrhagia, prolapse and other pelvic disorders in men and women.

Edward Thurman was named director of customer operations for Compressus (Washington). Thurman previously held management positions in customer operations at McKesson. Compressus specializes in integrated imaging and data management solutions.

• CoreValve (Irvine, California) has named Daniel Lemaitre CEO. He succeeds Jacques S guin, MD, PhD, co-founder of CoreValve, who will remain as chairman. Previously, Lemaitre has led Medtronic's corporate strategic planning and corporate development functions since 2006. CoreValve makes aortic valve replacement systems.

• Hooper Holmes (Basking Ridge, New Jersey) reported the appointment of David Winsemius, MD, as VP and medical director, and Danny Perkins as VP of sales, Heritage Labs. Winsemius was most recently VP and medical director for ING. Hooper Holmes provides risk assessment services to the insurance industry.

Gerald Kochanski was named CFO of Nephros. Kochanski joins the company from Lordi Consulting, where he was director since 2007. Nephros makes products for end-stage renal disease patients.

Louis Altobelli has been named VP and national sales manager for the physicans finance group of U.S. Bank Equipment Finance (Portland, Oregon). Altobelli previously was VP of business development, healthcare, with the company.

Anthony Rubino has resigned as CEO, CFO and sole director of U.S. MedSys (New York), effective March 31. Michael Black has been named CEO, CFO and sole director of the company. U.S. MedSys is a marketing and distribution organization that provides medical technology, support services and healthcare delivery.

Paul Risner has been named executive VP and general counsel, of U.S. Preventive Medicine (Dallas). Risner previously was VP, general counsel and secretary at BRCH. U.S. Preventive Medicine specializes in developing online personalized wellness programs.

Earl Fender has been named president/CEO and member of the board of VertiFlex (San Clemente, California). Most recently, Fender was VP/GM for Osiris Therapeutics. VertiFlex develops spinal technologies.

Laurie Mobley has been appointed associate director of the Washington office of WeissComm Partners (New York). Mobley previously was VP, group manager of the Washington office of Ketchum. WeissComm is a public relations agency focused on healthcare.